Amber Implants Bv

Amber Implants is a commercial-stage medical technology company with operations in the Netherlands and the US. Founded in 2018, the Company develops next-generation implants for spinal injuries with the goal of improving patient outcomes through more natural healing and enhanced spinal stability. Its flagship product, the VCFix® Spinal System, offers a simpler, more efficient, and safer approach for managing a broad range of spinal fractures. In June 2025, the Company reported one-year follow-up data for the VCFix® Spinal System from its first-in-human trial showing significant improvements in key clinical performance outcomes, and the device received FDA 510(k) Clearance from the US Food and Drug Administration (FDA) in September 2025. CAUTION: Investigational device. Limited by Federal law to investigational use